In January, the comapny reached 500 cases with Catalyst, according to a news release. It’s designed for spinal fusions and is made of a proprietary nanocrystalline structure that’s resorbed and replaced over time.
The bone graft was launched in the U.S. in August 2021.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
